Skip to content

Inspection Record

Lantheus Medical Imaging, Inc. — FDA 483 Findings

US FDAInspected 2026-04-09Published 2026-10-23 7 findingsMaterial and supplier controlLaboratory and QC controlsComputer system validationQuality unit oversightLabeling and packaging

Inspectors Daniel L Zheng · Lori M NewmanThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Material and supplier control

There is a failure to thoroughly review the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.

2Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate sampling plans and test procedures designed to assure that components and drug product containers conform to appropriate standards of identity, strength, quality and purity.

3Computer system validation

Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel.

4Material and supplier control

Access to the storage area for labels and labeling materials is not limited to authorized personnel.

5Material and supplier control

Component testing is deficient in that each component is not tested for conformity with all appropriate written specifications for purity, strength, and quality.

6Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.

7Labeling and packaging

Strict control is not exercised over labeling issued for use in drug product labeling operations.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-23. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Lantheus Medical Imaging, Inc. findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.